Labcorp affirms FY2026 adj EPS guidance at $18.10-$18.55
Labcorp Holdings (LH) affirmed FY2026 adjusted EPS guidance of $18.10–$18.55 versus a $18.01 analyst estimate. It also affirmed FY2026 sales guidance of $14.710B–$14.827B versus a $14.707B estimate.
Labcorp Holdings (NYSE: LH) affirmed its FY2026 adjusted EPS guidance at $18.10-$18.55, unchanged from the prior range, and compared it with the $18.01 analyst estimate. The company also kept its FY2026 sales outlook at $14.710 billion-$14.827 billion, unchanged from the prior range, versus the $14.707 billion estimate.